Literature DB >> 18705241

Inhibitors in mild/moderate haemophilia A: two case reports and a literature review.

Anna Chiara Giuffrida1, Sabrina Genesini, Massimo Franchini, Marzia De Gironcoli, Giuseppe Aprili, Giorgio Gandini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18705241      PMCID： PMC2626868          DOI： 10.2450/2008.0031-07

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  30 in total

Review 1.  Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years.

Authors:  P M Mannucci
Journal:  Haemophilia       Date:  2000-07       Impact factor: 4.287

2.  Factor VIII inhibitors in two families with mild haemophilia A: structural analysis of the mutations.

Authors:  K E Knobe; B O Villoutreix; L I Tengborn; P Petrini; R C Ljung
Journal:  Haemostasis       Date:  2000 Sep-Oct

Review 3.  Inhibitor antibodies to factor VIII and factor IX: management.

Authors:  J M Lusher
Journal:  Semin Thromb Hemost       Date:  2000       Impact factor: 4.180

4.  The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients.

Authors:  J Astermark; E Berntorp; G C White; B L Kroner
Journal:  Haemophilia       Date:  2001-05       Impact factor: 4.287

Review 5.  Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety.

Authors:  Stefan Lethagen
Journal:  Semin Thromb Hemost       Date:  2003-02       Impact factor: 4.180

6.  Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study.

Authors:  Samantha C Gouw; Johanna G van der Bom; H Marijke van den Berg
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

Review 7.  Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A.

Authors:  A Sharathkumar; D Lillicrap; V S Blanchette; M Kern; J Leggo; A M Stain; L Brooker; M D Carcao
Journal:  J Thromb Haemost       Date:  2003-06       Impact factor: 5.824

Review 8.  Molecular mechanisms of mild and moderate hemophilia A.

Authors:  M Jacquemin; M De Maeyer; R D'Oiron; R Lavend'Homme; K Peerlinck; J-M Saint-Remy
Journal:  J Thromb Haemost       Date:  2003-03       Impact factor: 5.824

Review 9.  The epidemiology of inhibitors in haemophilia A: a systematic review.

Authors:  J Wight; S Paisley
Journal:  Haemophilia       Date:  2003-07       Impact factor: 4.287

Review 10.  Control of bleeding in patients with haemophilia A with inhibitors: a systematic review.

Authors:  M Lloyd Jones; J Wight; S Paisley; C Knight
Journal:  Haemophilia       Date:  2003-07       Impact factor: 4.287
View more
  3 in total

Review 1.  Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management.

Authors:  Gary Benson; Günter Auerswald; Gerry Dolan; Anne Duffy; Cedric Hermans; Rolf Ljung; Massimo Morfini; Silva Zupančić Šalek
Journal:  Blood Transfus       Date:  2017-11-14       Impact factor: 3.443

Review 2.  Haemophilia.

Authors:  Erik Berntorp; Kathelijn Fischer; Daniel P Hart; Maria Elisa Mancuso; David Stephensen; Amy D Shapiro; Victor Blanchette
Journal:  Nat Rev Dis Primers       Date:  2021-06-24       Impact factor: 52.329

3.  Expert opinion on the UK standard of care for haemophilia patients with inhibitors: a modified Delphi consensus study.

Authors:  Kate Khair; Elizabeth Chalmers; Thuvia Flannery; Annabel Griffiths; Felicity Rowley; Guillermo Tobaruela; Pratima Chowdary
Journal:  Ther Adv Hematol       Date:  2021-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.